Literature DB >> 19130196

Hepatitis C virus infection and the brain.

Karin Weissenborn1, Anita B Tryc, Meike Heeren, Hans Worthmann, Henning Pflugrad, Georg Berding, Martin Bokemeyer, Hans L Tillmann, Annemarie Goldbecker.   

Abstract

There is growing evidence that hepatitis C virus (HCV)-infection may affect the brain. About half of the HCV-infected patients complain of chronic fatigue irrespective of their stage of liver disease or virus replication rate. Even after successful antiviral therapy fatigue persists in about one third of the patients. Many patients, in addition, report of deficits in attention, concentration and memory, some also of depression. Psychometric testing revealed deficits in attention and verbal learning ability as characteristic for HCV-afflicted patients with normal liver function. Magnetic resonance spectroscopic studies showed alterations of the cerebral choline, N-acetyl-aspartate, and creatine content in the basal ganglia, white matter and frontal cortex, respectively. Recently, pathologic cerebral serotonin and dopamine transporter binding and regional alterations of the cerebral glucose utilisation compatible with alterations of the dopaminergic attentional system were observed. Several studies detected HCV in brain samples or cerebro-spinal fluid. Interestingly, viral sequences in the brain often differed from those in the liver, but were closely related to those found in lymphoid tissue. Therefore, the Trojan horse hypothesis emerged: HCV-infected mononuclear blood cells enter the brain, enabling the virus to reside within the brain (probably in microglia) and to infect brain cells, especially astrocytes.

Entities:  

Mesh:

Year:  2009        PMID: 19130196     DOI: 10.1007/s11011-008-9130-5

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  36 in total

1.  Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy.

Authors:  E A Jones
Journal:  Lancet       Date:  1999-07-31       Impact factor: 79.321

2.  Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment.

Authors:  K Weissenborn; J C Ennen; M Bokemeyer; B Ahl; U Wurster; H Tillmann; C Trebst; H Hecker; G Berding
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

3.  Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease.

Authors:  Daniel M Forton; Howard C Thomas; Christine A Murphy; Joanna M Allsop; Graham R Foster; Janice Main; Keith A Wesnes; Simon D Taylor-Robinson
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

4.  Hepatitis C virus infection and neurocognitive function.

Authors:  M Soogoor; H S Lynn; S M Donfield; E Gomperts; T S Bell; E S Daar
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

5.  Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors.

Authors:  Mary Pat McAndrews; Karl Farcnik; Peter Carlen; Andrei Damyanovich; Mirela Mrkonjic; Susan Jones; E Jenny Heathcote
Journal:  Hepatology       Date:  2005-04       Impact factor: 17.425

6.  Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C.

Authors:  Robert J Fontana; Linas A Bieliauskas; Karen L Lindsay; Carla Back-Madruga; Elizabeth C Wright; Kristin K Snow; Anna S F Lok; Ziad Kronfol; Latha Padmanabhan
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

7.  Neuropsychological function in Greek patients with chronic hepatitis C.

Authors:  Katerina Karaivazoglou; Konstantinos Assimakopoulos; Konstantinos Thomopoulos; George Theocharis; Lambros Messinis; George Sakellaropoulos; Chryssoula Labropoulou-Karatza
Journal:  Liver Int       Date:  2007-08       Impact factor: 5.828

8.  [Changes in socio-economics, quality of life and knowledge of patients with chronic hepatitis C during the Hepatitis Competence Net Project].

Authors:  C Niederau; G Bemba; A Kautz
Journal:  Z Gastroenterol       Date:  2008-01       Impact factor: 2.000

9.  [Socio-economical aspects, quality of life and state of knowledge in hepatitis B patients. Socio-economical aspects in hepatitis B].

Authors:  C Niederau; C Fischer; A Kautz
Journal:  Z Gastroenterol       Date:  2007-05       Impact factor: 2.000

Review 10.  Fatigue in neurological disorders.

Authors:  Abhijit Chaudhuri; Peter O Behan
Journal:  Lancet       Date:  2004-03-20       Impact factor: 79.321

View more
  28 in total

1.  Rapid Regulation of Depression-Associated Genes in a New Mouse Model Mimicking Interferon-α-Related Depression in Hepatitis C Virus Infection.

Authors:  Carolina Hoyo-Becerra; Zijian Liu; Jinghong Yao; Britta Kaltwasser; Guido Gerken; Dirk M Hermann; Joerg F Schlaak
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

2.  Psychiatric care of the patient with hepatitis C: a review of the literature.

Authors:  Muhamad Aly Rifai; Ondria C Gleason; Douha Sabouni
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

3.  Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly.

Authors:  Kathrin Hueging; Mandy Doepke; Gabrielle Vieyres; Dorothea Bankwitz; Anne Frentzen; Juliane Doerrbecker; Frauke Gumz; Sibylle Haid; Benno Wölk; Lars Kaderali; Thomas Pietschmann
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

Review 4.  Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence.

Authors:  Alexander J Gill; Dennis L Kolson
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

Review 5.  Challenges in diagnosing hepatic encephalopathy.

Authors:  K Weissenborn
Journal:  Neurochem Res       Date:  2014-08-21       Impact factor: 3.996

6.  Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency.

Authors:  David A Sheridan; S H Bridge; M M E Crossey; D J Felmlee; H C Thomas; R D G Neely; S D Taylor-Robinson; M F Bassendine
Journal:  Metab Brain Dis       Date:  2014-03-12       Impact factor: 3.584

Review 7.  Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortality.

Authors:  Nobuyuki Toshikuni; Tomiyasu Arisawa; Mikihiro Tsutsumi
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 8.  Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015.

Authors:  Salvatore Monaco; Sara Mariotto; Sergio Ferrari; Massimiliano Calabrese; Gianluigi Zanusso; Alberto Gajofatto; Domenico Sansonno; Franco Dammacco
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

9.  Amphetamine dependence and co-morbid alcohol abuse: associations to brain cortical thickness.

Authors:  Glenn Lawyer; Petr S Bjerkan; Anders Hammarberg; Nitya Jayaram-Lindström; Johan Franck; Ingrid Agartz
Journal:  BMC Pharmacol       Date:  2010-05-20

Review 10.  Hepatitis C virus and neurological damage.

Authors:  Shilu Mathew; Muhammed Faheem; Sara M Ibrahim; Waqas Iqbal; Bisma Rauff; Kaneez Fatima; Ishtiaq Qadri
Journal:  World J Hepatol       Date:  2016-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.